Article
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype
In this work, we identify a new type I IFN–dependent psoriasis subtype resulting from rare heterozygous variants in ADAR1 and associated with a specific response to JAK1 and TYK2 inhibitors, opening new avenues in precision medicine in psoriatic disease.
